Results 81 to 90 of about 24,478,248 (209)

Plasma phosphorylated-tau217 is increased in Niemann–Pick disease type C [PDF]

open access: yes
Niemann–Pick disease type C and Alzheimer’s disease are distinct neurodegenerative disorders that share the presence of neurofibrillary tangle pathology.
Gonzalez-Ortiz, Fernando   +14 more
core   +1 more source

Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C

open access: yesOrphanet Journal of Rare Diseases, 2012
Background Niemann-Pick disease type C (NP-C) is a rare neurovisceral lysosomal lipid storage disease characterized by progressive neurological deterioration. Published data on the use of miglustat in paediatric patients in clinical practice settings are
Héron Bénédicte   +13 more
doaj   +1 more source

Distinct Niemann-Pick Disease Type C Clinical, Cytological, and Biochemical Phenotype in an Adult Patient With 1 Mutated, Overexpressed Allele

open access: yesJournal of Inborn Errors of Metabolism and Screening, 2015
Niemann-Pick disease type C (NP-C) is a rare autosomal-recessive neurovisceral lysosomal storage disease. We report on a juvenile onset, now 25-year-old female patient with typical neurologic symptoms, including vertical gaze palsy, of NP-C.
Julia Jecel MD   +6 more
doaj   +1 more source

Immune dysfunction in Niemann‐Pick disease type C

open access: yesJournal of Neurochemistry, 2015
AbstractLysosomal storage diseases are inherited monogenic disorders in which lysosome function is compromised. Although individually very rare, they occur at a collective frequency of approximately one in five thousand live births and usually have catastrophic consequences for health. The lysosomal storage diseases Niemann‐Pick disease type C (NPC) is
Platt, Nick   +7 more
openaire   +2 more sources

Niemann-Pick disease type C: nodular splenomegaly.

open access: yes, 1995
Niemann-Pick type C disease (NPCD) is an autosomal recessive storage lipidosis due to a disorder of cholesterol esterification leading to the accumulation of sphingomyelin and cholesterol in the brain, liver, and spleen.
Mentha G   +4 more
core   +1 more source

Miglustat in Niemann-Pick disease type c (NPC)

open access: yes, 2008
Miglustat in Niemann-Pick disease type c ...
Ed Wraith (15917000)   +4 more
core   +1 more source

Novel compound heterozygous mutations of the NPC1 gene associated with Niemann-pick disease type C: a case report and review of the literature

open access: yesBMC Infectious Diseases
Background Niemann-Pick Disease type C is a fatal autosomal recessive lipid storage disorder caused by NPC1 or NPC2 gene mutations and characterized by progressive, disabling neurological deterioration and hepatosplenomegaly.
Chaoxin Tao   +9 more
doaj   +1 more source

Consensus clinical management guidelines for Niemann-Pick disease type C

open access: yesOrphanet Journal of Rare Diseases, 2018
Niemann-Pick Type C (NPC) is a progressive and life limiting autosomal recessive disorder caused by mutations in either the NPC1 or NPC2 gene. Mutations in these genes are associated with abnormal endosomal-lysosomal trafficking, resulting in the ...
Tarekegn Geberhiwot   +25 more
doaj   +1 more source

Requirement of Npc1 and availability of cholesterol for early embryonic cell movements in zebrafish[S]

open access: yesJournal of Lipid Research, 2011
Niemann-Pick disease, type C (NP-C), often associated with Niemann-Pick disease, type C1 (NPC1) mu­tations, is a cholesterol-storage disorder characterized by cellular lipid accumulation, neurodegeneration, and reduced steroid production.
Tyler Schwend   +3 more
doaj   +1 more source

Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick Type C patient

open access: yes, 2010
New treatment options for Niemann-Pick Type C (NPC) have recently become available. To assess the efficiency and efficacy of these new treatment markers for disease status and progression are needed.
Lanyon, Linda J   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy